Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Here, we study the intricate relationship between gut microbiota and host cometabolic phenotypes associated with dietary-induced impaired glucose homeostasis and nonalcoholic fatty liver disease (NAFLD) in a mouse strain (129S6) known to be susceptible to these disease traits, using plasma and urine metabotyping, achieved by (1)H NMR spectroscopy. Multivariate statistical modeling of the spectra shows that the genetic predisposition of the 129S6 mouse to impaired glucose homeostasis and NAFLD is associated with disruptions of choline metabolism, i.e., low circulating levels of plasma phosphatidylcholine and high urinary excretion of methylamines (dimethylamine, trimethylamine, and trimethylamine-N-oxide), coprocessed by symbiotic gut microbiota and mammalian enzyme systems. Conversion of choline into methylamines by microbiota in strain 129S6 on a high-fat diet reduces the bioavailability of choline and mimics the effect of choline-deficient diets, causing NAFLD. These data also indicate that gut microbiota may play an active role in the development of insulin resistance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A causal role for the involvement of gut microbes is in part based on the fulfillment of one of Koch’s postulates - namely, the transmission of a disease related phenotype with transplantation of gut microbial organisms to a new host (Cho and Blaser, 2012; Cox et al., 2014; Dumas et al., 2006; Gregory et al., 2015; Koch, 1880; Sandhu and Chase, 1986).”
From Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis (2015) · cites this paper as Dumas et al., 2006
In the citing paper
“Interestingly, dysbiotic microbiota from mice fed a high-fat diet metabolize and convert dietary choline into methylamines, resulting in low circulating levels of plasma phosphatidylcholine60.”
From The gut microbiome and liver cancer: mechanisms and clinical translation (2017) · cites this paper as [60]
In the citing paper
“Serum and urinary concentrations of methylamines including TMAO were associated with the development of nonalcoholic fatty liver and impairment of glucose metabolism in high-fat-fed 129S6 mice (39).”
From Trimethylamine N -Oxide, the Microbiome, and Heart and Kidney Disease (2017) · cites this paper as [39]
In the citing paper
“It has been demonstrated that the gut microbiota can play a role in the development of metabolic abnormalities such as insulin resistance and nonalcoholic fatty liver disease76,77.”
From Dietary metabolism, the gut microbiome, and heart failure (2019) · cites this paper as [77]
Citations
Cites
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,808
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326
Host-Bacterial Mutualism in the Human Intestine
Bäckhed, F., Ley, R. E., Sonnenburg, J. L., Peterson, D. A., & Gordon, J. I. (2005) · Science · doi:10.1126/science.1104816 · Cited by 5,277
Metagenomic Analysis of the Human Distal Gut Microbiome
Gill, S. R., Pop, M., DeBoy, R. T., Eckburg, P. B., Turnbaugh, P. J., Samuel, B. S., Gordon, J. I., Relman, D. A., Fraser-Liggett, C. M., & Nelson, K. E. (2006) · Science · doi:10.1126/science.1124234 · Cited by 4,699
Nicholson, J. K., Lindon, J. C., & Holmes, E. (1999) · Xenobiotica · doi:10.1080/004982599238047 · Cited by 3,895
Self-citationMetabonomics: a platform for studying drug toxicity and gene function
Nicholson, J. K., Connelly, J., Lindon, J. C., & Holmes, E. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd728 · Cited by 1,914
Self-citation
Research works printed but not linked: 2
- A. L. Buchman, M. D. Dubin, A. A. Moukarzel, D. J. Jenden, M. Roch, K. M. Rice, J. Gornbein, M. E. Ament Hepatology 22, 1399–1403 (1995).
- S. H. Zeisel, J. S. Wishnok, J. K. Blusztajn J. Pharmacol. Exp. Ther. 225, 320–324 (1983).
Cited by
Items 401–500 of 942
Noecker, C. A., Chiu, H.-C., McNally, C. P., & Borenstein, E. (2019) · mSystems · doi:10.1128/msystems.00579-19 · Cited by 69
“In humans, such microbiome-derived metabolites have been identified as factors contributing to a wide array of diseases, including heart disease (3), autism (4), nonalcoholic fatty liver disease (5), colon cancer (6), inflammatory bowel disease (7), and susceptibility to infection (8).”
BackgroundSmall Intestinal Bacterial Overgrowth Is Associated with Non- Alcoholic Fatty Liver Disease
Fialho, A. B. C., Fialho, A., Thota, P. N., McCullough, A. J., & Shen, B. (2016) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld.2014.1121.252.iwg · Cited by 79
“Intestinal bacteria metabolize dietary choline to methylamines which are absorbed in the gut and converted in the liver to TMAO, a component that has been associated with fatty liver in mice [10].”
BackgroundIntra- and inter-omic fusion of metabolic profiling data in a systems biology framework
Richards, S. E., Dumas, M., Fonville, J. M., Ebbels, T. M. D., Holmes, E. C., & Nicholson, J. K. (2010) · Chemometrics and Intelligent Laboratory Systems · doi:10.1016/j.chemolab.2010.07.006 · Cited by 58
Self-citationChao, J., Cheng, H., Chang, M., Huang, S., Liao, J., Cheng, Y., Peng, W., & Pao, L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.606759 · Cited by 62
“The signals of the endogenous metabolites displayed on NMR spectra were categorized (Dumas et al., 2006; Xu et al., 2012; An et al., 2013; Shi et al., 2013), and Chenomx 7.”
BackgroundOrman, M., Bodea, S., Funk, M. A., Campo, A. M.-D., Bollenbach, M., Drennan, C. L., & Balskus, E. P. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b04883 · Cited by 69
Alterations in the redox state and liver damage: Hints from the EASL Basic School of Hepatology
Tell, G., Vascotto, C., & Tiribelli, C. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.09.018 · Cited by 67
“Modulation of adipokine imbalance can explain some of the favorable effects of weight loss [90].”
BackgroundElevated trimethylamine N -oxide related to ischemic brain lesions after carotid artery stenting
Wu, C., Li, C., Zhao, W., Xie, N., Yan, F., Lian, Y., Zhou, L., Xu, X., Liang, Y., Wang, L., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000005298 · Cited by 58
Verdugo‐Meza, A., Ye, J., Dadlani, H., Ghosh, S., & Gibson, D. L. (2020) · Nutrients · doi:10.3390/nu12051434 · Cited by 72
“Moreover, up to 32% of IBD patients show NAFLD [27] compared to 24% in the normal population [18].”
BackgroundInfluentialFitch, M. N., Phillippi, D., Zhang, Y., Lucero, J., Pandey, R. S., Liu, J., Brower, J., Allen, M. S., Campen, M. J., McDonald, J. D., et al. (2019) · Environmental Research · doi:10.1016/j.envres.2019.108913 · Cited by 73
“Specifically, alterations in the ratio of the two primary phyla of bacteria, Bacteroidetes and Firmicutes, has been associated with gut inflammation and systemic inflammatory disease states such as obesity, insulin resistance, and atherosclerosis (Alderete et al., 2018; Caesare et al., 2010; Dumas et al., 2006; Millio…”
BackgroundKrautkramer, K. A., Dhillon, R. S., Denu, J. M., & Carey, H. V. (2017) · Translational research · doi:10.1016/j.trsl.2017.08.005 · Cited by 63
Application of metabonomics in drug development.
Keun, H., & Athersuch, T. (2007) · Pharmacogenomics (London) · doi:10.2217/14622416.8.7.731 · Cited by 57
“Metabonomics, by its focus on systemic profiling, operates at this metabolic interface between an organism and its environment, and so presents the opportunity to generate biomarkers and models for the interactions between endogenous processes and exogenous compounds – including drugs [25–27].”
BackgroundTheofilis, P., Vordoni, A., & Kalaitzidis, R. (2022) · Metabolites · doi:10.3390/metabo12121243 · Cited by 69
“Additionally, an early experimental study pointed to the association of TMAO with insulin resistance as a driver of NAFLD [40].”
BackgroundRole of Bile Acids in Dysbiosis and Treatment of Nonalcoholic Fatty Liver Disease
Wang, C., Zhu, C., Shao, L., Ye, J., Shen, Y., & Ren, Y. (2019) · Mediators of Inflammation · doi:10.1155/2019/7659509 · Cited by 69
“Conversion of choline into methylamines by microbiota in strain 129S6 reduced the bioavailability of choline and mimicked the effect of cholinedeficient diets [92].”
BackgroundFatty Liver Disease and Gut Microbiota: A Comprehensive Update
Campo, L., Eiseler, S., Apfel, T., & Pyrsopoulos, N. (2019) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2018.00008 · Cited by 66
“Furthermore, as we noted before, Gram-negative bacteria contain lipopolysaccharides which promote chronic inflammation, metabolic dysfunction, insulin resistance, and diabetes.(13,34) In one study, mice that were bred to have a genetic predisposition to insulin resistance and NAFLD were fed a high-fat diet.”
BackgroundDong, X., Zhou, Z., Saremi, B., Helmbrecht, A., Wang, Z., & Loor, J. J. (2017) · Journal of Dairy Science · doi:10.3168/jds.2017-13351 · Cited by 62
Hernández‐Alonso, P., Cañueto, D., Giardina, S., Salas‐Salvadó, J., Cañellas, N., Correig, X., & Bulló, M. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.04.002 · Cited by 72
Rodríguez-Nunez, I., Caluag, T., Kirby, K., Rudick, C. N., Dziarski, R., & Gupta, D. (2017) · Scientific Reports · doi:10.1038/s41598-017-00484-2 · Cited by 65
Transfer of dysbiotic gut microbiota has beneficial effects on host liver metabolism
Nicolas, S., Blasco‐Baque, V., Fournel, A., Gilleron, J., Klopp, P., Waget, A., Ceppo, F., Marlin, A., Padmanabhan, R., Iacovoni, J. S., et al. (2017) · Molecular Systems Biology · doi:10.15252/msb.20167356 · Cited by 55
Contribution of Gut Bacteria to Lipid Levels: Another Metabolic Role for Microbes?
Allayee, H., & Hazen, S. L. (2015) · Circulation Research · doi:10.1161/circresaha.115.307409 · Cited by 64
Metabolomic analyses of faeces reveals malabsorption in cirrhotic patients
Huang, H., Zhang, A.-Y., Cao, H., Lu, H., Wang, B., Xie, Q., Xu, W., & Li, L. (2013) · Digestive and Liver Disease · doi:10.1016/j.dld.2013.01.001 · Cited by 63
“This technique offers great promise as an effective and on-invasive diagnostic method [4,5] and is a powerful approach or understanding the pathophysiology of diseases [6,7].”
MethodGomez-Santos, L., Luka, Z., Wagner, C., Fernandez-Alvarez, S., Lu, S. C., Mato, J. M., Martinez-Chantar, M. L., & Beraza, N. (2012) · Hepatology · doi:10.1002/hep.25694 · Cited by 61
The translational regulator FMRP controls lipid and glucose metabolism in mice and humans
Leboucher, A., Pisani, D. F., Martinez-Gili, L., Chilloux, J., Bermudez-Martin, P., Van Dijck, A., Ganief, T., Macek, B., Becker, J. A. J., Le Merrer, J., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.01.002 · Cited by 56
“(1)H NMR spectra were pre-processed and exported into Matlab for multivariate statistical analyses using orthogonal partial least square discriminant analysis (O-PLS-DA) as previously reported [24].”
MethodSelf-citationWu, Q., Wu, S., Yang, C., Zhang, Z., Mao, G., Li, S., Yang, Y., Zhang, X., Wu, M., & Tong, H. (2021) · Food & Function · doi:10.1039/d0fo03329d · Cited by 73
Chang, C., Wu, C., Su, W., Shih, K., Tarng, D., Chou, C., Chen, T.-Y., Kor, C., & Wu, H.-M. (2015) · Scientific Reports · doi:10.1038/srep10096 · Cited by 66
Metabolomic analysis of amino acid and fat metabolism in rats with l-tryptophan supplementation
Ruan, Z., Yang, Y., Wen, Y., Zhou, Y., Fu, X., Ding, S. L., Liu, G., Kang, Y., Wu, X., Deng, Z., et al. (2014) · Amino Acids · doi:10.1007/s00726-014-1823-y · Cited by 55
“Trimethylamine, TMAO, methylamine and dimethylamine, acetate and formate are microbial metabolites of carbohydrates and amino acids (Dumas et al. 2006; Louis et al. 2007; Smith et al. 1994; Walker et al. 2005), and they are likely produced in the lumen of the small intestine and large intestine.”
BackgroundWhole-body systems approaches for gut microbiota-targeted, preventive healthcare
Zhao, L., & Shen, J. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.02.008 · Cited by 53
“Their data also indicate that gut microbiota may play an active role in the development of insulin resistance (Dumas et al., 2006a).”
Gut Decontamination with Norfloxacin and Ampicillin Enhances Insulin Sensitivity in Mice
Chou, C. J., Membrez, M., & Blancher, F. (2008) · Nestlé Nutrition Workshop Series: Pediatric Program · doi:10.1159/000146256 · Cited by 58
The Gut Microbial Endocrine Organ in Type 2 Diabetes
Massey, W. J., & Brown, J. M. (2020) · Endocrinology · doi:10.1210/endocr/bqaa235 · Cited by 67
“In addition, recent studies suggest TMAO levels may similarly be associated with the presence and severity of non-alcoholic fatty liver disease (97-99), which can be a contributing factor in insulin resistance.”
BackgroundThe Natural Metabolite 4-Cresol Improves Glucose Homeostasis and Enhances β-Cell Function
Brial, F., Alzaïd, F., Sonomura, K., Meneyrol, K., Lay, A. L., Pean, N., Neves, A. L., Chilloux, J., Hedjazi, L., Sato, T.-A., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.066 · Cited by 64
“The occurrence of liver structural lesions resembling non-alcoholic fatty liver disease (NAFLD) is a phenotypic hallmark consistently observed in obesemice fed HFDs in our experimental conditions (Dumas et al., 2006).”
BackgroundSelf-citationNon-alcoholic fatty liver diseases: from role of gut microbiota to microbial-based therapies
Leylabadlo, H. E., Ghotaslou, R., Kafil, H. S., Feizabadi, M. M., Moaddab, S. Y., Farajnia, S., Sheykhsaran, E., Sanaie, S., Shanehbandi, D., & Baghi, H. B. (2019) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-019-03746-1 · Cited by 60
Metabolic Biomarkers in Heart Failure
Albert, C. L., & Tang, W. H. W. (2017) · Heart Failure Clinics · doi:10.1016/j.hfc.2017.08.011 · Cited by 75
Ma, B. W., Bokulich, N. A., Castillo, P. A., Kananurak, A., Underwood, M. A., Mills, D. A., & Bevins, C. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047416 · Cited by 54
“Mouse models have been at the forefront of research to elucidate the mechanisms that link the composition of the microbiota with normal physiology or disease [18,20–30].”
BackgroundRosberg-Cody, E., Stanton, C., O'Mahony, L., Wall, R., Shanahan, F., Quigley, E. M., Fitzgerald, G. F., & Ross, R. P. (2011) · Microbiology · doi:10.1099/mic.0.043406-0 · Cited by 60
Targeting Dysbiosis for the Treatment of Liver Disease
Anand, G., Zarrinpar, A., & Loomba, R. (2016) · Seminars in Liver Disease · doi:10.1055/s-0035-1571276 · Cited by 58
Starring role of toll-like receptor-4 activation in the gut-liver axis
Carotti, S. (2015) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v6.i4.99 · Cited by 57
Rojo, D., Gosalbes, M. J., Ferrari, R. G., Pérez‐Cobas, A. E., Hernández, E., Oltra, R., Buesa, J., Latorre, A., Barbas, C., Ferrer, M., et al. (2015) · The ISME Journal · doi:10.1038/ismej.2015.32 · Cited by 58
Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease
Zhou, J., Tripathi, M., Sinha, R. A., Singh, B. K., & Yen, P. M. (2021) · Hepatoma Research · doi:10.20517/2394-5079.2020.134 · Cited by 63
“In HFD-fed 126S6 mice, higher conversion of choline into TMA by microbiota resulted in lower bioavailability of choline([125]).”
BackgroundStreptozotocin-Induced Dynamic Metabonomic Changes in Rat Biofluids
Xu, W., Wu, J., An, Y., Xiao, C., Hao, F., Liu, H., Wang, Y., & Tang, H. (2012) · Journal of Proteome Research · doi:10.1021/pr300280t · Cited by 50
Hashemian, M., Merat, S., Poustchi, H., Jafari, E., Radmard, A.-R., Kamangar, F., Freedman, N. D., Hekmatdoost, A., Sheikh, M., Boffetta, P., et al. (2021) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001229 · Cited by 60
“High TMA has been shown to be associated with NAFLD in insulin-resistant mice (33).”
BackgroundKoopman, N., Molinaro, A., Nieuwdorp, M., & Holleboom, A. G. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15416 · Cited by 60
NAFLD, Helicobacter species and the intestinal microbiome
Castaño‐Rodríguez, N., Mitchell, H. M., & Kaakoush, N. O. (2017) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2017.09.008 · Cited by 55
Nakagawa, H. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i17.2110 · Cited by 63
Role of Gut Barrier Function in the Pathogenesis of Nonalcoholic Fatty Liver Disease
Dai, X., & Wang, B. (2015) · Gastroenterology Research and Practice · doi:10.1155/2015/287348 · Cited by 60
“(3) Reducing choline bioavailability in human body: deficiency of choline may result in the inability to synthesize phosphatidylcholine (PC) necessary for the assembly and secretion of very low-density lipoprotein (VLDL) and subsequent accumulation of triglyceride in liver [36].”
BackgroundAw, W., & Fukuda, S. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0456-2 · Cited by 57
Bariatric Surgery Modulates Circulating and Cardiac Metabolites
Ashrafian, H., Li, J. V., Spagou, K., Harling, L., Masson, P., Darzi, A., Nicholson, J. K., Holmes, E., & Athanasiou, T. (2014) · Journal of Proteome Research · doi:10.1021/pr400748f · Cited by 55
Self-citationTian, N., Wang, J., Wang, P., Song, X., Yang, M., & Kong, L. (2013) · Metabolomics · doi:10.1007/s11306-013-0535-8 · Cited by 53
“Choline is degraded in body to creatinine via dimethylglycine in mammalian or to methylamines (DMA, TMAO, and trimethylamine) by gut microbiota through symxenobiotic pathways (Dumas 2006).”
BackgroundMethodDynamic Metabolic Response of Mice to Acute Mequindox Exposure
Zhao, X.-J. G., Huang, C., Lei, H., Nie, X., Tang, H., & Wang, Y. (2011) · Journal of Proteome Research · doi:10.1021/pr2006457 · Cited by 52
Probiotics for the treatment of hyperlipidemia: Focus on gut-liver axis and lipid metabolism
You, M. S., Zhou, L., Wu, F., Zhang, L., Zhu, S.-X., & Zhang, H. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107694 · Cited by 57
Complex Network of NKT Cell Subsets Controls Immune Homeostasis in Liver and Gut
Marrero, I., Maricic, I., Feldstein, A. E., Loomba, R., Schnabl, B., Rivera-Nieves, J., Eckmann, L., & Kumar, V. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02082 · Cited by 54
“In addition, long-term feeding of a cholinedeficient high-fat diet mediate NASH and NASH-induced HCC by promoting liver infiltration by activated iNKT cells and Frontiers in Immunology | www.frontiersin.org 3 September 2018 | Volume 9 | Article 2082 CD8+ T cells and induction of inflammatory cytokines (52).”
InfluentialRemote Sensing Between Liver and Intestine: Importance of Microbial Metabolites
Fu, Z. D., & Cui, J. Y. (2017) · Current Pharmacology Reports · doi:10.1007/s40495-017-0087-0 · Cited by 56
Pomié, C., Blasco‐Baqué, V., Klopp, P., Nicolas, S., Waget, A., Loubières, P., Azalbert, V., Puel, A., Lopez, F., Dray, C., et al. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.03.004 · Cited by 60
“It was also shown that hepatic steatosis [6], atherosclerosis [7] as well as the therapeutic effect of bariatric surgery on obesity [8] and the deleterious effect of dietary lipids [9] were under the control, at least in part, of the gut microbiota.”
BackgroundLipid Metabolism by Gut Microbes and Atherosclerosis
Loscalzo, J. (2011) · Circulation Research · doi:10.1161/res.0b013e3182290620 · Cited by 54
Willing, B., & Kessel, A. V. (2010) · Livestock Science · doi:10.1016/j.livsci.2010.06.031 · Cited by 50
“could impact host function (Marchesi et al., 2007; Saric et al. 2008; Dumas et al., 2006).”
Gut Microbiota of Nonalcoholic Fatty Liver Disease
Abdou, R., Zhu, L., Baker, R. D., & Baker, S. S. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4045-1 · Cited by 56
“Interestingly, an HFD reduces the bioavailability of choline, mimicking the effect of CDD when given to mice susceptible to impaired glucose homeostasis and NAFLD [44].”
Tranchida, F., Shintu, L., Rakotoniaina, Z., Tchiakpe, L., Deyris, V., Hiol, A., & Caldarelli, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135948 · Cited by 49
“Furthermore, this depletion also suggests a possible involvement of gut microbiota, which in high fat diet-induced IR mice was found to convert dietary choline into methylamines with an increased level of methylamines urinary excretion, thereby reducing the biodisponibility of choline [35].”
BackgroundDynamic Omics Approach Identifies Nutrition-Mediated Microbial Interactions
Nakanishi, Y., Fukuda, S., Chikayama, E., Kimura, Y., Ohno, H., & Kikuchi, J. (2010) · Journal of Proteome Research · doi:10.1021/pr100989c · Cited by 54
Therapeutic implications of manipulating and mining the microbiota
Shanahan, F. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.174649 · Cited by 44
“2004), metabolic syndrome (Dumas et al. 2006) and insulin-dependent diabetes mellitus (Wen et al.”
BackgroundInfluentialRole of the intestinal microbiome in liver fibrosis development and new treatment strategies
Zhou, R., Fan, X., & Schnabl, B. (2019) · Translational research · doi:10.1016/j.trsl.2019.02.005 · Cited by 60
Tabbaa, M., Golubic, M., Roizen, M., & Bernstein, A. (2013) · Nutrients · doi:10.3390/nu5083299 · Cited by 43
“Changes to gut bacteria have been suspected to play a role in obesity, fatty liver, diabetes, and cardiovascular disease [33–38].”
BackgroundPlant-Based Foods as a Source of Lipotropes for Human Nutrition: A Survey of In Vivo Studies
Fardet, A., & Chardigny, J. (2013) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2010.549596 · Cited by 52
“The use of specific mice strains that mimic a choline-deficient diet has also been reported (Dumas et al, 2006 ).”
BackgroundGut Microbiota at the Crossroad of Hepatic Oxidative Stress and MASLD
Termite, F., Archilei, S., D’Ambrosio, F., Petrucci, L., Viceconti, N., Iaccarino, R., Liguori, A., Gasbarrini, A., & Miele, L. (2025) · Antioxidants · doi:10.3390/antiox14010056 · Cited by 63
Chen, H., Gao, D., Wang, B., Zhao, R., Guan, M., Zheng, L., Zhou, X., Chai, Z., & Feng, W.-Y. (2014) · Nanotechnology · doi:10.1088/0957-4484/25/16/165101 · Cited by 57
“dysbiosis caused by diet or drugs has been demonstrated to have detrimental effects on human health and may cause several diseases, such as inflammatory bowel disease [27], non-alcoholic fatty liver disease [11], obesity [19], cancer [4], and HIV infection [34].”
BackgroundFatty liver and the metabolic syndrome
Neuschwander-Tetri, B. A. (2007) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32801421a9 · Cited by 113
Bariatric Surgery and Liver Disease: General Considerations and Role of the Gut–Liver Axis
Cerreto, M., Santopaolo, F., Gasbarrini, A., Pompili, M., & Ponziani, F. R. (2021) · Nutrients · doi:10.3390/nu13082649 · Cited by 61
Sun, S., Yang, M., Fu, H., Ge, X., & Zou, J. (2020) · Aquaculture · doi:10.1016/j.aquaculture.2020.735431 · Cited by 50
Metabolic profiling of type 1 diabetes mellitus in children and adolescents: a case–control study
Bervoets, L., Massa, G., Guedens, W., Louis, E., Noben, J., & Adriaensens, P. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0246-9 · Cited by 59
“Choline metabolism also depends on the gut microbial composition [18], making the latter an attractive target for early prevention and treatment of T1DM [19].”
BackgroundWaller‐Evans, H., Hue, C., Fearnside, J., Rothwell, A. R., Lockstone, H. E., Caldérari, S., Wilder, S. P., Cazier, J., Scott, J., & Gauguier, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082825 · Cited by 55
“In contrast, in strictly identical experimental conditions, HFD-fed BALB/c mice did not show evidence of liver triglyceride accumulation and were devoid of NAFLD, even though levels of ALT and AST were increased in both strains in response to HFD [13], suggesting the involvement of genetically driven mechanisms of res…”
BackgroundResultInfluentialSelf-citationLi, J., Liu, B., Li, F., He, Y., Wang, L., Kulyar, M. F., Li, H., Fu, Y., Zhu, H., Wang, Y., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.712092 · Cited by 51
Prathomya, P., Prisingkorn, W., Jakovlić, I., Deng, F.-Y., Zhao, Y., & Wang, W. (2017) · Metabolomics · doi:10.1007/s11306-016-1158-7 · Cited by 60
Scorletti, E., & Byrne, C. D. (2016) · Digestive Diseases · doi:10.1159/000447276 · Cited by 40
Schnackenberg, L. K. (2007) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.7.3.247 · Cited by 49
Radziejewska, A., Muzsik, A., Milagro, F. I., Martínez, J. A., & Chmurzyńska, A. (2019) · Lifestyle Genomics · doi:10.1159/000504602 · Cited by 47
Does the Gut Microbiota Contribute to Obesity? Going beyond the Gut Feeling
Aguirre, M., & Venema, K. (2015) · Microorganisms · doi:10.3390/microorganisms3020213 · Cited by 62
“Conversion of choline into choline metabolites and the reduction of the bioavailability of choline itself in humans and mice have been associated with metabolic syndrome and plasma lipids [69] and non-alcoholic fatty liver disease [70].”
BackgroundThe Intestinal Microbiota and Liver Disease
Bajaj, J. S., Hylemon, P. B., & Younossi, Z. (2012) · The American Journal of Gastroenterology Supplements · doi:10.1038/ajgsup.2012.3 · Cited by 56
Session 2: Personalised nutrition Metabolomic applications in nutritional research
Brennan, L. (2008) · Proceedings of The Nutrition Society · doi:10.1017/s0029665108008719 · Cited by 47
“The concept of a metabolic phenotype or metabotype has been previously introduced((19,27)), and it is proposed to be influenced by a combination of genetic and environmental factors such as diet.”
BackgroundThe Potential of Bile Acids as Biomarkers for Metabolic Disorders
Yin, C., Zhong, R., Zhang, W., Liu, L., Chen, L., & Zhang, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512123 · Cited by 49
“Amongst others, choline is essential for the transportation of lipids, the methylation of proteins, and the synthesis of neurotransmitters such as glycine, glutamate, and gamma aminobutyric acid (abbreviated as GABA) [33,34]; short-chain fatty acids (SCFAs) including acetate, propionate, and butyrate, are now a well-r…”
BackgroundTrimethylamine N-Oxide and Stroke Recurrence Depends on Ischemic Stroke Subtypes
Xu, J., Cheng, A., Song, B., Zhao, M., Xue, J., Wang, A., Dai, L., Jing, J., Meng, X., Li, H., et al. (2021) · Stroke · doi:10.1161/strokeaha.120.031443 · Cited by 56
Wijarnpreecha, K., Lou, S. M., Watthanasuntorn, K., Kröner, P. T., Cheungpasitporn, W., Lukens, F., Pungpapong, S., Keaveny, A. P., & Ungprasert, P. (2019) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001541 · Cited by 71
Phenotyping non‐alcoholic fatty liver disease by the gut microbiota: Ready for prime time?
Demir, M., Lang, S., Martin, A., Farowski, F., Wisplinghoff, H., Vehreschild, M. J. G. T., Krawczyk, M. J., Nowag, A., Scholz, C. J., Kretzschmar, A., et al. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15071 · Cited by 53
Yamamoto, M., Pinto-Sánchez, M. I., Berčík, P., & Britz‐McKibbin, P. (2019) · Metabolomics · doi:10.1007/s11306-019-1543-0 · Cited by 60
Metabolic Response to Oral Microcystin-LR Exposure in the Rat by NMR-Based Metabonomic Study
He, J., Chen, J., Wu, L., Li, G., & Xie, P. (2012) · Journal of Proteome Research · doi:10.1021/pr300685g · Cited by 48
The Microbial-Mammalian Metabolic Axis: Beyond Simple Metabolism
Dumas, M. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.04.005 · Cited by 40
“…current study focuses on butyrate and colonocytes, investigating the interaction between microbial metabolites and other mammalian tissues such as liver (Dumas et al., 2006) or arteries (Wang et al., 2011) in the case of methylamines should shed new light on the fine regulation of human metabolism.”
BackgroundSelf-citationRak, K., & Rader, D. J. (2011) · Nature · doi:10.1038/472040a · Cited by 49
From microbiome to metabolism: Bridging a two-decade translational gap
Hul, M. V., & Cani, P. D. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.10.011 · Cited by 57
Gueniche, A., Perin, O., Bouslimani, A., Landemaine, L., Misra, N., Cupferman, S., Aguilar, L., Clavaud, C., Chopra, T., & Khodr, A. (2022) · Pathogens · doi:10.3390/pathogens11020121 · Cited by 44
A Role for Gut Microbiome Fermentative Pathways in Fatty Liver Disease Progression
Iruzubieta, P., Medina, J. M., Fernández-López, R., Crespo, J., & de la Cruz, F. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051369 · Cited by 47
Interleukin-15 Modulates Adipose Tissue by Altering Mitochondrial Mass and Activity
Barra, N. G., Palanivel, R., Denou, E., Chew, M. V., Gillgrass, A., Walker, T. D., Kong, J., Richards, C. D., Jordana, M., Collins, S. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114799 · Cited by 40
Nonalcoholic fatty liver disease is associated with benign gastrointestinal disorders.
Reddy, S. K., Zhan, M., Alexander, H., & El-Kamary, S. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i45.8301 · Cited by 42
Vernocchi, P., Vannini, L., Gottardi, D., Del Chierico, F., Serrazanetti, D. I., Ndagijimana, M., & Guerzoni, M. E. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00156 · Cited by 41
“Frontiers in Cellular and Infection Microbiology www.frontiersin.org December 2012 | Volume 2 | Article 156 | 3 Dumas et al. (2006) have recently applied 1H-NMR technique to characterize the intergenome interactions in mice with synbiotic gut microbiota as well as to monitor the gut-microbial…”
MethodFeng, J., Liu, H., Zhang, L., Bhakoo, K. K., & Lu, L. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/39/395101 · Cited by 47
“The metabonomics approach has been successfully used to investigate several contrasting biological processes including safety assessment [16], toxicological effects [17, 18], disease processes [19, 20] and nutritional intervention [21, 22].”
MethodYi, X., Ren, M., Yang, J., Cai, C., Cheng, W., Zhou, X., Lu, D., & Ji, F. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1003755 · Cited by 48
“Administering TMAO to mouse models of HFD-induced NAFLD and aggravated liver steatosis by shifting the hepatic BA composition to FXR-antagonism and inhibiting the hepatic FXR signaling that consequently upregulates lipogenesis (Tan et al., 2019).”
BackgroundInfluentialMicrobiota Contribute to Obesity-Related Increases in the Pulmonary Response to Ozone
Tashiro, H., Cho, Y., Kasahara, D. I., Brand, J. D., Bry, L., Yeliseyev, V., Abu-Ali, G., Huttenhower, C., & Shore, S. A. (2019) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0144oc · Cited by 56
Effect of Saccharomyces boulardii and Bacillus subtilis B10 on gut microbiota modulation in broilers
Qin, C., Gong, L., Zhang, X., Wang, Y., Wang, Y., Wang, B., Li, Y., & Li, W. (2018) · Animal nutrition · doi:10.1016/j.aninu.2018.03.004 · Cited by 56
“, 2006), fatty liver (Dumas et al., 2006), and anxiety (Neufeld et al.”
BackgroundPathophysiology of Nonalcoholic Fatty Liver Disease: Lifestyle-Gut-Gene Interaction
Mazzotti, A., Caletti, M. T., Sasdelli, A. S., Brodosi, L., & Marchesini, G. (2016) · Digestive Diseases · doi:10.1159/000447275 · Cited by 41
Jiménez-González, C., Alonso‐Peña, M., Vélez, P. A., Crespo, J., & Iruzubieta, P. (2025) · Nutrients · doi:10.3390/nu17091580 · Cited by 46
Examining the gut-liver axis in liver cancer using organoid models
Shek, D., Chen, D., Read, S. A., & Ahlenstiel, G. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.04.008 · Cited by 40
Jichitu, A., BUNGAU, S. G., Stănescu, A. M. A., Vesa, C. M., Toma, M. M., Bustea, C., Iurciuc, S., Rus, M., Bacalbaşa, N., & Diaconu, C. C. (2021) · Diagnostics · doi:10.3390/diagnostics11040689 · Cited by 56
“Gut microbiota: Studies have shown that a diet rich in fats in mice that develop NAFLD altered the manufacturing of metabolites dependent on intestinal flora, including trimethylamine (TMA) [153].”
BackgroundYang, Y., Zhang, H., Yan, B., Zhang, T., Gao, Y. H., Shi, Y., & Le, G. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b02003 · Cited by 47
Shrinet, J., Shastri, J., Gaind, R., Bhavesh, N., & Sunil, S. (2016) · Scientific Reports · doi:10.1038/srep36833 · Cited by 40
“In recent times metabolic profiling of biofluids has provided additional information to gain insight into disease prognosis and to develop diagnostic biomarkers 20–22 .”
Wu, X., Li, N., Li, H., & Tang, H. (2013) · The Analyst · doi:10.1039/c3an02100a · Cited by 50
Metadata
- Authors
- Dumas, M.-E., Barton, R. H., Toye, A., Cloarec, O., Blancher, C., Rothwell, A., Fearnside, J., Tatoud, R., Blanc, V., Lindon, J. C., Mitchell, S. C., Holmes, E., McCarthy, M. I., Scott, J., Gauguier, D., & Nicholson, J. K.
- Affiliations
- Imperial College London (GB)
- *Department of Biological Chemistry and
- Centre for Human Genetics (GB)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2006-08-15
- Volume
- 103
- Issue
- 33
- Pages
- 12511-12516
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1567909
- OpenAlex
- W2139464173
- Cited by
- 1,042
- References
- 0
- Citations by year
- 2026: 11 · 2025: 19 · 2024: 29 · 2023: 26 · 2022: 43 · 2021: 57 · 2020: 52 · 2019: 80 · 2018: 70 · 2017: 67 · 2016: 86 · 2015: 72 · 2014: 63 · 2013: 80 · 2012: 62
- FWCI
- 17.42
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust (057733, 066786)
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- gut microbiota, non-alcoholic fatty liver disease, insulin resistance, choline metabolism, phosphatidylcholine, trimethylamine N-oxide, methylamine, high-fat diet, impaired glucose homeostasis, metabotyping, host-microbe interactions, choline deficiency
- MeSH terms
- Animals, Body Weight, Dietary Fats, Fatty Liver, Glucose, Homeostasis, Insulin, Insulin Resistance, Lipids, Liver, Male, Methylamines, Mice, Inbred BALB C, Phenotype, Multivariate Analysis, Nuclear Magnetic Resonance, Biomolecular, Gastrointestinal Tract, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.